Focused On-demand Libraries - Receptor.AI Collaboration


Explore the Potential with AI-Driven Innovation

Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.


We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by Reaxense.


Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.


We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.


 

Fig. 1. The screening workflow of Receptor.AI

The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.


Our library is unique due to several crucial aspects:


  • Receptor.AI compiles all relevant data on the target protein, such as past experimental results, literature findings, known ligands, and structural data, thereby enhancing the likelihood of focusing on the most significant compounds.

  • By utilizing advanced molecular simulations, the platform is adept at locating potential binding sites, rendering the compounds in the focused library well-suited for unearthing allosteric inhibitors and binders for hidden pockets.

  • The platform is supported by more than 50 highly specialized AI models, all of which have been rigorously tested and validated in diverse drug discovery and research programs. Its design emphasizes efficiency, reliability, and accuracy, crucial for producing focused libraries.

  • Receptor.AI extends beyond just creating focused libraries; it offers a complete spectrum of services and solutions during the preclinical drug discovery phase, with a success-dependent pricing strategy that reduces risk and fosters shared success in the project.


PARTNER
Receptor.AI
 
UPACC
Q9Y2D0

UPID:
CAH5B_HUMAN

ALTERNATIVE NAMES:
Carbonate dehydratase VB; Carbonic anhydrase VB

ALTERNATIVE UPACC:
Q9Y2D0; A8K4T5

BACKGROUND:
The enzyme Carbonic anhydrase 5B, mitochondrial, with alternative names Carbonate dehydratase VB and Carbonic anhydrase VB, is essential for the reversible hydration of carbon dioxide. This process is fundamental for cellular pH regulation and the efficient transport of CO2, a critical aspect of cellular respiration.

THERAPEUTIC SIGNIFICANCE:
Exploring the functionalities of Carbonic anhydrase 5B, mitochondrial offers a promising pathway for the development of novel therapeutic approaches. Given its central role in CO2 metabolism and pH balance, targeting this enzyme could lead to breakthroughs in treating metabolic and respiratory diseases.

Looking for more information on this library or underlying technology? Fill out the form below and we will be in touch with all the details you need.